Related Experiment Video
Updated: Jun 11, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
307
Olanzapine-Induced Acute Pulmonary Embolism
Jihane Moussaoui1, Ikram Saadi1, Mohammed Barrimi1
1Psychiatry, Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, MAR.
Cureus
|October 7, 2024
Summary
A rare case of massive acute pulmonary embolism occurred in a patient taking olanzapine. Early recognition and management are crucial for this life-threatening condition.
Area of Science:
- Cardiology
- Pulmonology
- Pharmacology
Background:
- Pulmonary embolism (PE) is a critical condition caused by a blockage in the pulmonary arteries, often originating from deep vein thrombosis.
- PE is frequently underdiagnosed and carries a significant risk of mortality.
- Olanzapine is an antipsychotic medication with potential cardiovascular side effects.
Observation:
- This report details a rare instance of a massive acute pulmonary embolism in a patient undergoing treatment with olanzapine.
- The patient's presentation highlights an unusual adverse event associated with olanzapine therapy.
Findings:
- The case underscores the potential, though rare, association between olanzapine use and the development of acute pulmonary embolism.
- This observation emphasizes the need for vigilance regarding thromboembolic events in patients using olanzapine.
Implications:
- Clinicians should consider pulmonary embolism in patients using olanzapine who exhibit suggestive symptoms.
- Awareness of this rare complication can aid in the timely prevention and management of life-threatening thromboembolic events.
- Further research may be warranted to explore the potential link between olanzapine and pulmonary embolism.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
2
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
2
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
3
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3
01:27Pulmonary Embolism III: Nursing Management
6
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
6
01:20Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
01:26Psychosis: Goals of Pharmacotherapy
110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110
01:21Acute Respiratory Failure-II
179
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179